The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Zai Lab Limited ADR shares valued at $1,428,650 were sold by Du Ying on May 13 ’25. At $28.57 per share, Du Ying sold 50,000 shares. The insider’s holdings dropped to 479,851 shares worth approximately $15.02 million following the completion of this transaction.
Also, Du Ying sold 46,389 shares, netting a total of over 1,302,857 in proceeds. Following the sale of shares at $28.09 each, the insider now holds 479,851 shares.
Before that, Du Ying had added 46,389 shares to its account. In a trade valued at $1,340,642, the Officer bought Zai Lab Limited ADR shares for $28.90 each.
As published in their initiating research note from Scotiabank on March 07, 2025, Zai Lab Limited ADR [ZLAB] has been a Sector outperform and the price target has been revised to $55. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of December 14, 2023, Morgan Stanley has initiated its “an Overweight” rating for ZLAB. Earlier on August 10, 2023, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for ZLAB stock.
Analyzing ZLAB Stock Performance
During the last five days, there has been a drop of approximately -3.93%. Over the course of the year, Zai Lab Limited ADR shares have jumped approximately 19.55%. Shares of the company reached a 52-week high of $39.77 on 03/28/25 and a 52-week low of $23.82 on 01/15/25.
Support And Resistance Levels for Zai Lab Limited ADR (ZLAB)
According to the 24-hour chart, there is a support level at 30.96, which, if violated, would cause prices to drop to 30.61. In the upper region, resistance lies at 31.50. The next price resistance is at 31.69. RSI (Relative Strength Index) is 51.14 on the 14-day chart, showing neutral technical sentiment.
